Log in to search using one of your social media accounts:

 

LVC Timing in Infant Pig Swallowing and the Effect of Safe Swallowing

AbstractRecurrent laryngeal nerve (RLN) injury in neonates, a complication of head and neck surgeries, leads to increased aspiration risk and swallowing dysfunction. The severity of resulting sequelae range from morbidity, such as aspiration pneumonia, to mortality from infection and failure to thrive. The timing of airway protective events including laryngeal vestibule closure (LVC) is implicated in aspiration. We unilaterally transected the RLN in an infant pig model to observe changes in the timing of swallowing kinematics with lesion and aspiration. We recorded swallows using high-speed video-fluoroscopic swallow studies (VFSS) and scored them using the Infant Mammalian Penetration and Aspiration Scale (IMPAS). We hypothesized that changes would occur in swallowing kinematics (1) between RLN lesion and control animals, and (2) among safe swallows (IMPAS 1), penetration swallows (IMPAS 3), and aspiration swallows (IMPAS 7). We observed numerous changes in timing following RLN lesion in safe and unsafe swallows, suggesting pervasive changes in the coordination of oropharyngeal function. The timing of LVC, posterior tongue, and hyoid movements differed between pre- and post-lesion in safe swallows. Posterior tongue kinematics differed for post-lesion swallows with penetration. The timing and duration of LVC and posterior tongue movement differed between aspiration swallows pre- and post-lesion. After lesion, safe swallows and swallows with aspiration differed in timing of LV...
Source: Dysphagia - Category: Speech-Language Pathology Source Type: research

Related Links:

Nabriva Therapeutics announced positive results Monday from its second large-scale, late-stage clinical trial of its experimental therapy for community-acquired bacterial pneumonia (CABP). The biopharmaceutical company, which has operations in Dublin, Ireland and King of Prussia, plans to file a new drug application for the therapy – called Lefamulin – with the Food and Drug Administration during the fourth quarter of this year. Nabriva’s stock surged by more than 20 percent in pre-market…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
(Reuters) - Nabriva Therapeutics Plc's antibiotic drug to treat a common form of pneumonia met the main goal of a key clinical trial, but concerns over its side effects sent the drug developer's shares down 13 percent on Monday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Condition:   Pneumonia, Mycoplasma Interventions:   Drug: Doxycycline;   Drug: Azithromycin Sponsor:   National Taiwan University Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
(Reuters) - Nabriva Therapeutics Plc said on Monday its antibiotic to treat adults with a common form of pneumonia met the main goal of a second late-stage study, putting the company on track to file for the drug's approval in the fourth quarter of 2018.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
By SAURABH JHA Of my time arguing with doctors, 30 % is spent convincing British doctors that their American counterparts aren’t idiots, 30 % convincing American doctors that British doctors aren’t idiots, and 40 % convincing both that I’m not an idiot. A British doctor once earnestly asked whether American physicians carry credit card reading machines inside their white coats. Myths about the NHS can be equally comical. British doctors don’t prostate every morning in deference to the NHS, like the citizens of Oceania sang to Big Brother in Orwell’s dystopia. Nor, in their daily rounds, do the...
Source: The Health Care Blog - Category: Consumer Health News Authors: Tags: OP-ED Uncategorized AlfieEvans Source Type: blogs
(Reuters) - Nabriva Therapeutics Plc's pneumonia drug for adults met the main goal of a late-stage study, the company said on Monday, putting it on track to file a marketing application with U.S. regulators later this year.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause associated with the histopathologic and/or radiologic pattern of usual interstitial pneumonia (UI...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Tags: Research article Source Type: research
In order to decrease the incidence of ventilator-associated pneumonia (VAP) in Belgium, a national campaign for implementing a VAP bundle involving assessment of sedation, cuff pressure control, oral care with...
Source: Annals of Intensive Care - Category: Intensive Care Authors: Tags: Research Source Type: research
ConclusionsOperative fixation of a flail chest in trauma patients results in a lower rate of pneumonia, less mechanical ventilation days and shorter hospital stay, compared with non-operative treatment, but at the cost of surgery-related complications requiring invasive solutions in some cases.
Source: European Journal of Trauma and Emergency Surgery - Category: Emergency Medicine Source Type: research
ConclusionsThe ILD-GAP model underestimated mortality, and the SADL model underestimated mortality in certain subgroups. However, the GAP model performed well in this cohort, providing the best prognostic information for SSc-ILD.
Source: Lung - Category: Respiratory Medicine Source Type: research
More News: Pneumonia | Speech-Language Pathology | Study